DOV vs STOK · P/E 27, rev $4.24B vs rev $15.6M
Dover Corporation (DOV) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. STOK currently screens at market cap $1.88B.
Not investment advice. Open the DOV and STOK stock pages for the full models.
Not investment advice.